Profile
ACIU VRTX REGN SGEN ALNY ARGX
Company Name AC Immune SA Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $154.35M $130.72B $60.54B $43.15B $35.25B $34.28B
Employees 0.13K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Dr. Andrea Pfeifer Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACIU VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 3
Quant Rating Sell Sell Buy Neutral Strong Sell Neutral
Trading
ACIU VRTX REGN SGEN ALNY ARGX
Last Close $1.48 $489.1 $563.16 $228.74 $234.56 $596.2
High 52 $4.87 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $1.48 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -69.61 % -5.35 % -53.14 % 0 % -20.96 % -11.25 %
Price vs. 52 Week Low 0 % 24.51 % 3.07 % 0 % 63.67 % 67.47 %
Total Return
ACIU VRTX REGN SGEN ALNY ARGX
1 Month Return -33.61 % -4.52 % -15.34 % 0 % -3.99 % -2.45 %
3 Month Return -44.78 % 15.9 % -17.37 % 0 % -4.75 % -6.92 %
6 Month Return -52.72 % 1.26 % -43.15 % 0 % -20.74 % 5.52 %
9 Month Return -59.23 % 0.2 % -47.23 % 0 % -0.9 % 27.79 %
YTD Return -45.19 % 21.46 % -20.94 % 0 % -0.32 % -3.06 %
1 Year Return -37.82 % 24.3 % -37.01 % 0 % 61.59 % 66.35 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 114.31 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
ACIU VRTX REGN SGEN ALNY ARGX
Asset Growth 26.31 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth 168.61 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth 84.51 % 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year - 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year -84.22 % 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year -54.59 % 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth 2.32 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth 6.12 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share 52.5 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share -171.88 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share -338.52 % 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth 2.32 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) 209 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG 168.26 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -23.51 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG 288.04 % 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth 28.13 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth 21.88 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share -46.22 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share -67.04 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share -73.57 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share 140.79 % 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth 55.19 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth 206.63 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ACIU VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM -18.29 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -22.05 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -39.89 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -40.27 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 100.01 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 97.2 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -191.8 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM 1213.23 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM 12.4 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 12.15 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 337.65 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 11.83 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM 0.6 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM 0.59 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 150.36 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM 241.1 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.13 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM 1213.23 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM 1.93 -165.4 16.83 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM 2.13 -266.09 13.71 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM 2.13 -266.09 13.71 -203.89 -4192.79 -531.16
Income Statement (TTM)
ACIU VRTX REGN SGEN ALNY ARGX
Revenue $0.03B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0.03B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.05B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.5 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACIU VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.12B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0.11B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0.13B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.23B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ACIU VRTX REGN SGEN ALNY ARGX
Net Income $-0.05B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.07B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.72
ABCL AbCellera Biologics Inc. 2.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.84
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9008
ABPWW 0.0465
ABSI Absci Corporation 3.09
ABUS Arbutus Biopharma Corporation 3.15
ABVC ABVC BioPharma, Inc. 0.855
ABVX Abivax SA American Depositary Shares 6.4
ACAD ACADIA Pharmaceuticals Inc. 14.73
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5258
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 1.99
ACLX Arcellx, Inc. 62.02
ACRV Acrivon Therapeutics, Inc. Common Stock 1.81
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.01091 118.29
GWX SPDR S&P International Small Cap ETF 0.02 32.54
BIB ProShares Ultra Nasdaq Biotechnology 0.00690109 41.39
SBIO ALPS Medical Breakthroughs ETF 0.002 26.48
BMED BlackRock Future Health ETF 0.03832 22.9086
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 19.82
DFAT Dimensional U.S. Targeted Value ETF 0.00025756 47.38
DFAS Dimensional U.S. Small Cap ETF 0.00012545 55.67
DFAC Dimensional U.S. Core Equity 2 ETF 0.00006775 30.86
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03527 5.034
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0169 5.7275
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.0169 5.711
QQQS Invesco NASDAQ Future Gen 200 ETF 0.406 21.15
DFSU Dimensional US Sustainability Core 1 ETF 0.0002681 33.62
DXUV Dimensional ETF Trust 0.00002704 46.95
Unlock